Literature DB >> 11263758

On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder.

M L Carlsson1.   

Abstract

1. The objective of the present study was to compare the phenomenology and pathophysiology of obsessive compulsive disorder (OCD) and attention deficit hyperactivity disorder/deficits in attention, motor control and perception (ADHD/DAMP). 2. Through detailed studies of the literature on OCD and ADHD/DAMP, the phenomenology of these two conditions is compared, and possible underlying pathophysiological mechanisms involving interactions between glutamate, dopamine, serotonin and acetylcholine are discussed, with emphasis on OCD. The present paper also discusses possible mechanisms of action for current pharmacological treatments of OCD and ADHD, as well as possible future treatment strategies for these disorders. 3. OCD and ADHD/DAMP are common neuropsychiatric conditions which in many regards appear to be each other's antipodes with respect to clinical manifestations, associated personality traits and brain biochemistry, notably prefrontal cortical glutamate activity. Future pharmacological treatments of these disorders may involve manipulations with glutamate, dopamine D , serotonin 2A and nicotine receptors. 4. It appears that OCD is a hyperglutamatergic and ADHD a hypoglutamatergic condition, with prefrontal brain regions being especially affected.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11263758     DOI: 10.1016/s0278-5846(00)00146-9

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  26 in total

1.  High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

Authors:  W Louis Cleveland; Robert L DeLaPaz; Rashid A Fawwaz; Roger S Challop
Journal:  Neural Plast       Date:  2010-02-18       Impact factor: 3.599

2.  Differential neuroimaging indices in prefrontal white matter in prenatal alcohol-associated ADHD versus idiopathic ADHD.

Authors:  Joseph O'Neill; Mary J O'Connor; Victor Yee; Ronald Ly; Katherine Narr; Jeffrey R Alger; Jennifer G Levitt
Journal:  Birth Defects Res       Date:  2019-01-29       Impact factor: 2.344

Review 3.  Obsessive-compulsive disorder, impulse control disorders and drug addiction: common features and potential treatments.

Authors:  Leonardo F Fontenelle; Sanne Oostermeijer; Ben J Harrison; Christos Pantelis; Murat Yücel
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

Review 4.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors:  Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal:  Pharmacol Ther       Date:  2011-09-22       Impact factor: 12.310

Review 5.  N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.

Authors:  Olivia Dean; Frank Giorlando; Michael Berk
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

6.  In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD).

Authors:  Mohammad Haghighi; Leila Jahangard; Hamid Mohammad-Beigi; Hafez Bajoghli; Hassan Hafezian; Alireza Rahimi; Hamid Afshar; Edith Holsboer-Trachsler; Serge Brand
Journal:  Psychopharmacology (Berl)       Date:  2013-03-23       Impact factor: 4.530

7.  Brain activation during cognitive planning in twins discordant or concordant for obsessive-compulsive symptoms.

Authors:  Anouk den Braber; Dennis van 't Ent; Danielle C Cath; Judith Wagner; Dorret I Boomsma; Eco J C de Geus
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

8.  A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.

Authors:  Göran Starck; Maria Ljungberg; Marie Nilsson; Lars Jönsson; Stefan Lundberg; Tord Ivarsson; Susanne Ribbelin; Sven Ekholm; Arvid Carlsson; Eva Forssell-Aronsson; Maria L Carlsson
Journal:  J Neural Transm (Vienna)       Date:  2008-06-05       Impact factor: 3.575

9.  The uncompetitive NMDA receptor antagonists ketamine and memantine preferentially increase the choice for a small, immediate reward in low-impulsive rats.

Authors:  Pietro Cottone; Attilio Iemolo; Aditi R Narayan; Jina Kwak; Duncan Momaney; Valentina Sabino
Journal:  Psychopharmacology (Berl)       Date:  2012-10-27       Impact factor: 4.530

10.  Dopamine regulates the expression of the glutamate transporter GLT1 but not GLAST in developing striatal astrocytes.

Authors:  Veronica I Brito; Verena E Rozanski; Cordian Beyer; Eva Küppers
Journal:  J Mol Neurosci       Date:  2009-08-15       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.